Showing results 1 to 7 of 7
Title | Author(s) | Issue Date | |
---|---|---|---|
31-Oct-2022 | |||
Hyperpolarization-activated cyclic nucleotide-gated channel (HCN) blocker, Ivabradine, a novel potential targeted treatment for triple-negative breast cancer. Proceeding/Conference:European Journal of Cancer | 2018 | ||
KPNA1 mediates the nuclear import of BQ323636.1 and confer tamoxifen resistance in breast cancer cells Proceeding/Conference:Cancer Research | 2018 | ||
KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
2020 | |||
Repurposing hyperpolarization‐activated cyclic nucleotide‐gated channels as a novel therapy for breast cancer Journal:Clinical and Translational Medicine | 2021 | ||
Translational regulation by eIF4E and its contribution to tamoxifen resistance in breast cancer Proceeding/Conference:Cancer Research | 2016 |